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Abstract
The treatment of H4-IIE cells (an immortalised liver cell line derived from the Reuber rat hepatoma) with thapsigargin,
2,5-di-(tert-butyl)-1,4-benzohydroquinone, cyclopiazonic acid, or pretreatment with EGTA, stimulated Ca2 inflow (assayed
using intracellular fluo-3 and a Ca2 add-back protocol). No stimulation of Mn2 inflow by thapsigargin was detected.
Thapsigargin-stimulated Ca2 inflow was inhibited by Gd3 (maximal inhibition at 2 WM Gd3), the imidazole derivative
SKpF 96365, and by relatively high concentrations of the voltage-operated Ca2 channel antagonists, verapamil, nifedipine,
nicardipine and the novel dihydropyridine analogues AN406 and AN1043. The calmodulin antagonists W7, W13 and
calmidazolium also inhibited thapsigargin-induced Ca2 inflow and release of Ca2 from intracellular stores. No inhibition
of either Ca2 inflow or Ca2 release was observed with calmodulin antagonist KN62. Substantial inhibition of Ca2 inflow
by calmidazolium was only observed when the inhibitor was added before thapsigargin. Pretreatment of H4-IIE cells with
pertussis toxin, or treatment with brefeldin A, did not inhibit thapsigargin-stimulated Ca2 inflow. Compared with freshly
isolated rat hepatocytes, H4-IIE cells exhibited a more diffuse actin cytoskeleton, and a more granular arrangement of the
endoplasmic reticulum (ER). In contrast to freshly isolated hepatocytes, the arrangement of the ER in H4-IIE cells was not
affected by pertussis toxin treatment. Western blot analysis of lysates of freshly isolated rat hepatocytes revealed two forms
of Gi2K with apparent molecular weights of 41 and 43 kDa. Analysis of H4-IIE cell lysates showed only the 41 kDa form of
Gi2K and substantially less total Gi2K than that present in rat hepatocytes. It is concluded that H4-IIE cells possess store-
operated Ca2 channels which do not require calmodulin for activation and exhibit properties similar to those in freshly
isolated rat hepatocytes, including susceptibility to inhibition by relatively high concentrations of voltage-operated Ca2
channel antagonists. In contrast to rat hepatocytes, SOCs in H4-IIE cells do not require Gi2K for activation. Possible
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1. Introduction
Hepatocytes are polarised epithelial cells which
perform a wide variety of physiological functions in-
cluding metabolite and energy interconversion, the
synthesis and secretion of proteins and bile acids,
and the metabolism of xenobiotic compounds (re-
viewed in [1]). These processes are regulated by hor-
mones, many of which use increases in the cytoplas-
mic free Ca2 concentration ([Ca2]cyt) as an
intracellular signal (reviewed in [1,2]). Store-operated
Ca2 channels (SOCs), a sub-family of the receptor-
activated Ca2 channels (RACCs), play an essential
role in the generation of these intracellular Ca2 sig-
nals [2^4]. In hepatocytes, as in other animal cells,
SOCs replenish Ca2 lost from intracellular stores
during agonist action and may also mediate the pro-
vision of extracellular Ca2 to speci¢c regions of the
cytoplasmic space to generate speci¢c types of Ca2
signal [5^7]. SOCs are de¢ned as plasma membrane
Ca2 channels, the activation of which is initiated by
a decrease in Ca2 in the endoplasmic reticulum
(ER) caused by the action of inositol 1,4,5-trisphos-
phate (InsP3) [5]. An important sub-type of SOCs are
the Ca2 release-activated Ca2 channels (CRACs),
which exhibit a high selectivity for Ca2 and low
single channel conductance (reviewed in [6]). SOCs
can be activated experimentally by the treatment of
cells with inhibitors of the ER (Ca2+Mg2)ATPase
(SERCA) such as thapsigargin, 2,5-di-(tert-butyl)-
1,4-benzohydroquinone (DBHQ) and cyclopiazonic
acid (CPA) [5].
The structures and mechanisms of activation of
SOCs are not well understood [5^7]. There is some
evidence to indicate that mammalian homologues of
the Drosophila melanogaster photoreceptor cell tran-
sient receptor potential (TRP) Ca2 channel are the
molecular forms of some SOCs, although further ex-
periments are required to test this idea [6^8]. A fea-
ture of the activation of rat hepatocyte SOCs is a
requirement for the trimeric GTP-binding protein
(G-protein), Gi2K [9,10], and a monomeric G-protein,
possibly an Arf protein [4]. These G-proteins may be
involved in maintaining the correct intracellular lo-
cation of the ER, and communication within the lu-
men of the ER [4]. Further elucidation of the struc-
tures and mechanisms of activation of hepatocyte
SOCs would be greatly enhanced by the use of mo-
lecular biology techniques (e.g. the transient or stable
expression of antisense DNA or RNA encoding
channel proteins or regulatory proteins) together
with an immortalised liver cell line which possesses
SOCs with the same characteristics as those in hep-
atocytes.
Several immortalised liver cell lines have permitted
signi¢cant contributions to be made to the present
understanding of the Ca2 and other intracellular
signalling pathways in the liver [11^14]. While these
cell lines retain many of the functions and character-
istics of di¡erentiated hepatocytes, they are smaller
in size, their intracellular structures are generally not
polarised, and they do not express some character-
istic liver cell proteins, including some hormone re-
ceptors [11^14]. While there is evidence that liver cell
lines exhibit InsP3-induced Ca2 release from the ER
[12] and Ca2-activated non-selective cation channels
[13], there is limited information about the nature of
SOCs in liver cell lines.
The aim of the present experiments was to deter-
mine whether the H4-IIE cell line, derived from the
Reuber rat hepatoma [11], expresses SOCs, and
whether these Ca2 channels have the same character-
istics as those described in freshly isolated rat hepato-
cytes. The results indicate that H4-IIE cells possess
SOCs which are inhibited by low concentrations of
Gd3 and by relatively high concentrations of some
L-type voltage-operated Ca2 channel (VOCC) antag-
onists. In contrast to SOCs in rat hepatocytes, the
activation of SOCs in H4-IIE cells does not require
the trimeric GTP-binding regulatory protein, Gi2.
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2. Materials and methods
2.1. Materials
Thapsigargin, 2,5-di-(tert-butyl)-1,4-benzohydro-
quinone (DBHQ), cyclopiazonic acid (CPA), calm-
idazolium, W7 (N-(6-amino-hexyl)-5-chloro-1-naph-
thalenesulfonamide), W13 (N-(4-aminobutyl)-5-
chloro-2-naphthalenesulfonamide), 1-[N,O-bis(5-iso-
quinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiper-
azine (KN62), verapamil, nifedipine, nicardipine and
pertussis toxin were from Sigma-Aldrich; SKpF
96365 from Sapphire Bioscience, Alexandria, NSW;
gadolinium chloride hexahydrate from Aldrich, WI,
USA; calciseptine from Molecular Probes; benzyl-
amiloride hydrochloride (benzamil) from Research
Biochemical, Natick, MA, USA; and AN406 and
AN1043 were kindly provided by Athena Neuro-
sciences, San Francisco, USA. A⁄nity-puri¢ed poly-
clonal anti-GiK antibody, raised against the C-termi-
nal decapeptide (KENLKDCGLF) of the K-subunit
of transducin, was kindly provided by Dr. Michael
Crouch (John Curtin School of Medical Research,
Australian National University, Canberra). Although
this antibody detects both Gi1K and Gi2K , liver does
not express detectable Gi1K [15], so that the G-protein
detected by this antibody in the present experiments
is Gi2K . All other chemicals were obtained from sour-
ces described previously [4,14,16].
2.2. Cell culture
H4-IIE cells (ATCC CRL 1548) were cultured at
37‡C in 5% (v/v) CO2 in air in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) supplemented with peni-
cillin (100 U/ml), streptomycin (100 Wg/ml), 10 mM
HEPES (pH 7.4) and 10% (v/v) foetal bovine serum
(complete DMEM) [14]. The £asks were seeded with
approximately 0.5U106 cells (25-cm2 £asks) or
1.5U106 cells (75-cm2 £asks). The incubation me-
dium was changed every 2 days and cultures were
normally con£uent in 1 week. The cells were subcul-
tured by treatment with trypsin (0.1% w/v) and
EDTA (0.2% w/v) in saline (0.9% w/v NaCl) contain-
ing glucose (0.1% w/v). H4-IIE cells were sub-cul-
tured for a maximum of 15 passages. Hepatocytes
were isolated from rat liver by perfusion with colla-
genase, plated onto collagen-coated coverslips in
plastic dishes, and grown in primary culture as de-
scribed previously [9]. Rats were treated with pertus-
sis toxin as described previously [9].
2.3. Measurement of the intracellular free Ca2+
concentrations, release of Ca2+ from intracellular
stores and rates of Ca2+ in£ow
H4-IIE cells suspended in complete DMEM were
plated onto circular collagen-coated [9] glass cover-
slips (22 mm diameter, approximately 0.6U106 cells
per coverslip) and incubated for 24 h at 37‡C in an
atmosphere of 5% (v/v) CO2 in air in order to create
a monolayer. In some experiments, this incubation
was performed in the presence of either pertussis
toxin (0.5 Wg/ml), brefeldin A (20 WM) or vehicle.
The cells were loaded with £uo-3 by incubation of
the coverslip/H4-IIE cell monolayer with 40 WM £uo-
3 acetoxymethylester in the presence of pluronic F-
127 acid (0.05% (v/v)) in DMEM containing bovine
serum albumin (2% w/v) for 30 min at 37‡C in 5% (v/
v) CO2 in air. The coverslip/H4-IIE cell monolayer
was then washed twice at 37‡C in 117 mM NaCl, 4.7
mM KCl, 1.2 mM MgSO4, 24 mM NaHCO3, 20
mM TES, adjusted to pH 7.4 with KOH (modi¢ed
Krebs^Henseleit [17] bu¡er) and mounted in a tem-
perature-controlled incubation chamber (Applied
Imaging, UK) which was placed on the microscope
stage. Modi¢ed Krebs^Henseleit bu¡er (with, or
without, added Ca2 as indicated in the tables and
legends to ¢gures) (300 Wl) was added. In experi-
ments in which either Gd3 or Mn2 was employed,
the modi¢ed Krebs^Henseleit bu¡er was replaced by
a ‘simpli¢ed medium’ [18] (SO234 omitted in order to
minimise the precipitation of Gd3 or Mn2) com-
posed of 118 mM NaCl, 5.8 mM KCl, 1.2 mM
MgCl2, 25 mM NaHCO3 and 20 mM TES, adjusted
to pH 7.4 with NaOH.
The £uorescence of a ¢eld of H4-IIE cells (approx-
imately 300^400 cells) loaded with £uo-3 was mea-
sured at 34‡C using an inverted Nikon TMD-EF
£uorescence microscope, a U40 glycerol immersion
objective lens, and either a P1 photometer (Nikon)
and the UMANS ¢lter changer and computer soft-
ware [4] or a ¢lter wheel (Sutter), intensi¢ed CCD
camera (ISIS-3/S20, Photonic Science) and Axon
Imaging Workbench (V. 2.1) software. Excitation
was at 490 nm and a Nikon B2A ¢lter block was
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used to isolate emitted light. Neutral density ¢lters
(1.0, 2.3 or 2.6 as required) were incorporated into
the excitation light path in order to decrease photo-
bleaching. Values of maximum (Fmax) and minimum
(Fmin) £uorescence were estimated at the end of each
experiment by the addition of 5 WM ionomycin (in
the presence of 1.2 mM Ca2) and 6 mM EGTA (in
60 mM Tris, pH 8.8), respectively, and converted to
[Ca2]cyt as described by Thomas and Delaville [19]
using a value of 400 nM for the Kd for the associa-
tion of Ca2 with £uo-3 [20].
The location of £uo-3 in the cytoplasmic space of
H4-IIE cells was veri¢ed as follows. Fluo-3-loaded
cells were treated with either saponin (50 Wg/ml) or
digitonin (40 WM) to selectively disrupt the plasma
membrane, but not intracellular membranes [19].
Each of these agents released 90% of the cell-associ-
ated £uo-3, indicating that the dye was principally
located in the cytoplasmic space. This conclusion
was con¢rmed by inspection of the location of £uo-
3 £uorescence in images of £uo-3-loaded H4-IIE cells
(results not shown).
Amounts of Ca2 released from intracellular stores
(in cells incubated in the absence of added Ca2o )
following the addition of a SERCA inhibitor were
estimated by measuring the di¡erence between the
peak (maximum) value of [Ca2]cyt (nM) induced
by the SERCA inhibitor and the value of [Ca2]cyt
before SERCA inhibitor addition. Rates of Ca2 in-
£ow were estimated using the Ca2 add-back proto-
col [4]. This involves the addition of Ca2o (1.2 mM
except as indicated otherwise (Table 1)) to cells pre-
viously incubated in the absence of added Ca2o and
in the presence of a SERCA inhibitor, and measure-
ment of the initial rate of the Ca2o -induced increase
in [Ca2]cyt (expressed as nM Ca2cyt per s). Results
shown in the ¢gures are representative of the number
of traces indicated, while those in the tables and text
are the means þ S.E.M. of those obtained for the
number of coverslips indicated. Degrees of signi¢-
cance were determined using Student’s t-test for un-
paired samples.
2.4. Locations of the actin cytoskeleton and
endoplasmic reticulum
The locations of the actin cytoskeleton and ER in
freshly isolated rat hepatocytes in primary culture
Table 1
The stimulation of Ca2 in£ow in H4-IIE cells by treatment with the SERCA inhibitor thapsigargin or pretreatment with EGTA to
deplete intracellular stored Ca2
Treatment Inhibitor Thapsigargin-induced Ca2
release (nM)
Initial rate of Ca2 in£ow
(nM/s)
None None ^ 0.77 þ 0.18 (5)
None Gd3 (10 WM) ^ 0.42 þ 0.22 (5)
Thapsigargin addition None 301 þ 50 (9) 6.47 þ 0.70 (9)
Thapsigargin addition Gd3 (10 WM) 416 þ 116 (6) 1.09 þ 0.27 (16)***
Thapsigargin addition SKpF 96365 (20 WM) 176 þ 40 (6)** 1.65 þ 0.5 (6)***
EGTA pretreatment None ^ 3.63 þ 0.67 (16)
EGTA pretreatment SKpF 96365 (20 WM) ^ 0.57 þ 0.10 (5)***
EGTA pretreatment/thapsigargin addition None 72 þ 19 (3) 3.79 þ 0.98 (3)
EGTA pretreatment/thapsigargin addition SKpF 96365 (20 WM) 25 þ 26 (3) 1.57 þ 0.1 (3)*
Measurement of the £uorescence of a ¢eld of H4-IIE cells loaded with £uo-3 and calculation of the amounts of Ca2 released from
intracellular stores and the initial rates of Ca2 in£ow were performed as described in Section 2. Pretreatment of cells with EGTA
was achieved by the addition of 1.0 mM EGTA to cells incubated in the absence of added Ca2 at the beginning of the period of the
measurement of £uorescence. For incubations conducted in the absence of thapsigargin, Ca2 (5.2 mM when EGTA was present, and
4.2 mM when EGTA was absent) was added 6 min after beginning the measurement of £uorescence. Thapsigargin (10 WM), when
present, was added 1 min after beginning the measurement of £uorescence, and 4.2 mM Ca2 was added when the thapsigargin-in-
duced increase in £uorescence had returned to baseline. Gd3 and SKpF 96365 were added at the beginning of the period of the mea-
surement of £uorescence. The data are the means þ S.E.M. for the number of coverslips indicated in parentheses. The degrees of sig-
ni¢cance, determined using Student’s t-test for unpaired samples, for a comparison of values obtained in the presence of a given
inhibitor with those obtained in the absence of inhibitor, were: *P6 0.05; **P6 0.02; and ***P6 0.001.
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and H4-IIE cells attached to collagen-coated cover-
slips were determined using Texas Red-X phalloidin
and DiOC6(3), respectively, and confocal microsco-
py, as described previously [16].
2.5. Western blot analysis
Freshly isolated rat hepatocytes and H4-IIE cells
were lysed in 50 mM HEPES (pH 7.4) containing 1%
(w/v) Triton X-100, 150 mM NaCl, 1 mM EGTA,
1 mM Na3VO4, 100 mM NaF, 10 mM Na4P2O7,
10% (w/v) glycerol, supplemented with 1 mM dithio-
threitol, 0.2 mM phenylmethanesulfonyl £uoride,
10 Wg/ml leupeptin and 10 Wg/ml pepstatin A, and
the lysates were quantitatively mixed with Laemmli
sample bu¡er [21]. SDS^PAGE was performed on
12% polyacrylamide resolving gels with the Laemmli
discontinuous bu¡er system [21] at 250 V for 1 h.
The resolved proteins were electro-transferred to ni-
trocellulose membranes by the method of Towbin et
al. [22] using a Bio-Rad mini transblot electropho-
retic transfer unit. Membranes were blocked with 1 M
glycine containing 5% (w/v) non-fat milk powder, 5%
(v/v) foetal calf serum and 1% (w/v) ovalbumin for
1 h at room temperature, incubated ¢rstly with anti-
GiK antibody (1:200 dilution) overnight at 4‡C and
subsequently with secondary antibody (goat anti-rab-
bit IgG conjugated to alkaline phosphatase, 1:1000
dilution) for 2 h at room temperature, and ¢nally
developed for 5 min in 100 mM Tris^HCl (pH 9.5),
100 mM NaCl and 5 mM MgCl2 containing 0.33 mg/
ml nitro blue tetrazolium and 0.16 mg/ml bromo-
chloroindolyl phosphate.
3. Results
3.1. Activation of Ca2+ in£ow by SERCA inhibitors
and by pretreatment with EGTA
The treatment of H4-IIE cells with the SERCA
inhibitor thapsigargin induced a stimulation of
Ca2 in£ow as assessed by the Ca2o -dependent pla-
teau observed in the plot of [Ca2]cyt as a function of
time in cells incubated in the presence of Ca2o and
thapsigargin (Fig. 1A; cf. Fig. 1B, upper trace, show-
ing e¡ect of thapsigargin in the absence of added
Ca2o ), and by the thapsigargin-dependent increase
in [Ca2]cyt observed when Ca2o was added to cells
previously incubated in the absence of added Ca2o
(Fig. 1B and Table 1). Maximal stimulation of Ca2
in£ow was observed at 1 WM thapsigargin and near-
maximal stimulation at 0.1 WM (results not shown).
Ca2 in£ow was also stimulated by 2,5-di-(tert-bu-
tyl)-1,4-benzohydroquinone (DBHQ) and cyclopia-
zonic acid (Fig. 1C,D). In order to decrease the con-
centration of Ca2 in the ER by a process which
does not involve an increase in [Ca2]cyt (cf. the ac-
tion of a SERCA inhibitor, which induces an in-
crease in [Ca2]cyt (Fig. 1B^D)), cells were pretreated
with EGTA. This procedure caused a 4-fold increase
in the initial rate of Ca2 in£ow, measured using the
Ca2 add-back protocol (Table 1). EGTA pretreat-
ment was associated with a decrease in the thapsigar-
gin-induced Ca2 release (Table 1), indicating that
EGTA pretreatment causes a substantial decrease
in the amount of Ca2 in intracellular stores. The
initial rates of Ca2 in£ow in cells pretreated with
EGTA or with EGTA and thapsigargin are lower
than those in cells treated with thapsigargin alone
(Table 1). This may be due to the lower free
[Ca2]o employed in the experiments conducted in
the presence of EGTA, and/or to an e¡ect of
EGTA on the plasma membrane Ca2 channel pro-
tein.
Since some SOCs and other RACCs admit
Mn2 as well as Ca2 (reviewed in [6,7]), the e¡ect
of thapsigargin on Mn2 in£ow to H4-IIE cells
was investigated. The addition of Mn2 (200 WM)
to cells loaded with £uo-3 and incubated in the
absence of added Ca2o , and in either the absence
or presence of thapsigargin (10 WM), did not cause
a detectable decrease in the £uorescence of intracel-
lular £uo-3. The rates of decrease in £uo-3 £uores-
cence in the presence of Mn2, and absence and
presence of thapsigargin were 30.02 þ 0.02 and
0.001 þ 0.002 £uorescence units/s, respectively (n = 4,
two cell prepa- rations). The subsequent addi-
tion of ionomycin (10 WM) caused a substantial
decrease in £uorescence which was dependent upon
the presence of extracellular Mn2 (results not
shown), indicating that the failure to detect the
quenching of £uo-3 £uorescence by Mn2 was not
due to an inability of intracellular £uo-3 to detect
such a change.
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3.2. Inhibition of Ca2+ in£ow by Gd3+, voltage-
operated Ca2+ channel antagonists and
calmodulin antagonists
Thapsigargin-stimulated Ca2 in£ow was com-
pletely inhibited by Gd3, an inhibitor of Ca2 re-
lease-activated Ca2 channels and other SOCs
[6,7,18], with maximum inhibition observed at 2 WM
total added Gd3 (Tables 1 and 2). At low concen-
trations, Gd3 had no substantial e¡ect on thapsigar-
gin-induced release of Ca2 from intracellular stores
(Table 2). SKpF 96365, an inhibitor of SOCs and
some other RACCs [23], caused substantial inhibi-
tion of thapsigargin-stimulated Ca2 in£ow with lit-
tle e¡ect on thapsigargin-induced release of Ca2
from intracellular stores (Tables 1 and 2). SKpF
96365 also inhibited EGTA-induced Ca2 in£ow
(Table 1). The degree of inhibition by SKpF 96365
Fig. 1. SERCA inhibitors induce Ca2 in£ow in H4-IIE cells. (A) E¡ects of thapsigargin in the presence of Ca2o . (B^D) E¡ects of
the successive addition of a given SERCA inhibitor and Ca2o to cells previously incubated in the absence of added Ca
2
o . The SER-
CA inhibitors employed were thapsigargin (B), DBHQ (C) and cyclopiazonic acid (D). In A, cells were incubated initially in the pres-
ence of Ca2o (1.2 mM) and thapsigargin (10 WM) added at a time indicated by the arrow. In B^D, cells were incubated initially in
the absence of added Ca2o . Thapsigargin (10 WM) (B), DBHQ (25 WM) (C) or cyclopiazonic acid (50 WM) (D) and Ca
2
o (1.2 mM)
were added at the times indicated by the arrows. H4-IIE cells attached to collagen-coated coverslips were loaded with £uo-3, and the
£uorescence of a ¢eld of cells measured as described in Section 2. The traces shown are representative of those obtained for one of
three to ¢ve experiments which gave similar results.
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of EGTA-induced Ca2 in£ow was similar to that
for thapsigargin-stimulated Ca2 in£ow (Table 1).
It was not possible to test the ability of Gd3 to
inhibit EGTA-induced Ca2 in£ow since EGTA
binds Gd3 with an a⁄nity considerably greater
than that with which it binds Ca2 and would be
expected to chelate added Gd3 [24]. No inhibition
of thapsigargin-stimulated Ca2 in£ow was observed
with benzylamiloride hydrochloride (benzamil), an
inhibitor of Na^Ca2 exchange [25], at concentra-
tions of 0.2, 0.5, 1.0 or 10 WM which have been
shown to inhibit Na^Ca2 exchange in other cell
types (results not shown).
Previous studies have shown that one type of
RACC, most likely a SOC, in freshly isolated rat
hepatocytes is inhibited by high concentrations of
L-type VOCC antagonists [26,27], and mRNA en-
coding isoforms of L-type VOCCs has been detected
in rat hepatocytes and H4-IIE cells [14]. Moreover,
in T and B lymphocytes, which might be regarded as
‘non-excitable’ cells, VOCCs have been shown to be
activated by agonists and to play a role in mediating
agonist-induced Ca2 in£ow [28]. Therefore, the ef-
fects of L-type VOCC antagonists on thapsigargin-
stimulated Ca2 in£ow in H4-IIE cells were investi-
gated. Verapamil, nifedipine, nicardipine [29] and the
novel dihydropyridines AN406 and AN1043 [30]
each caused some inhibition of thapsigargin-stimu-
lated Ca2 in£ow in H4-IIE cells (Table 2). No inhi-
bition of thapsigargin-stimulated Ca2 in£ow by the
Ca2 antagonist, calciseptine, was observed at con-
centrations at or below 10 WM (results not shown).
Table 2
Inhibition of thapsigargin-stimulated Ca2 in£ow in H4-IIE cells by Gd3, SKpF 96365 and inhibitors of voltage-operated Ca2
channels
Inhibitor Concentration (WM) Thapsigargin-induced Ca2
release (nM)
Initial rate of thapsigargin-stimulated
Ca2 in£ow (nM/s)
Gd3 0 245 þ 30 (9) 8.3 þ 1.4 (9)
2 293 þ 95 (4) 0.7 þ 0.2 (4)3
10 346 þ 85 (9) 1.0 þ 0.2 (9)3
50 471 þ 33 (4)3 1.3 þ 0.3 (4)3
SKpF96365 0 226 þ 64 (2) 8.8 þ 2.4 (2)
50 143 þ 9 (4) 2.8 þ 1.2 (4)**
Verapamil 0 243 þ 42 (3) 15.0 þ 1.8 (3)
20 246 þ 50 (3) 10.1 þ 1.1 (3)*
100 46 þ 13 (3)*** 5.2 þ 1.2 (3)***
Nifedipine 0 211 þ 19 (10) 11.2 þ 2.3 (10)
20 212 þ 28 (8) 7.6 þ 1.6 (8)
100 242 þ 35 (8) 6.8 þ 1.5 (8)*
Nicardipine 0 268 þ 26 (19) 10.4 þ 1.7 (9)
50 340 þ 33 (20) 5.7 þ 1.1 (20)***
100 277 þ 33 (6) 5.8 þ 0.8 (6)***
AN406 0 231 þ 36 (14) 11.7 þ 1.9 (14)
10 450 þ 91 (3) 11.7 þ 2.4 (3)
20 101 þ 13 (6)3 9.4 þ 2.6 (6)
50 123 þ 27 (6)*** 8.9 þ 3.2 (6)
AN1043 0 234 þ 43 (10) 12.9 þ 2.5 (10)
50 250 þ 42 (4) 9.0 þ 3.5 (4)
100 218 þ 59 (5) 6.6 þ 2.3 (5)*
Measurement of the £uorescence of a ¢eld of H4-IIE cells loaded with £uo-3 and calculation of the amounts of Ca2 released from
intracellular stores and the initial rates of Ca2 in£ow were performed as described in Section 2. Gd3, SKpF 96365 and verapamil
were added at the beginning of the period for the measurement of £uorescence. Nifedipine, nicardipine, AN406 and AN1043 were
added at the beginning of the period of loading with £uo-3. For the experiments conducted with Gd3, a ‘simpli¢ed medium’ was em-
ployed (Section 2). The initial rate of Ca2 in£ow (Ca2o -induced increase in [Ca
2]cyt) in the absence of thapsigargin was 0.77 þ 0.18
(5) nM/s. The data are the means þ S.E.M. of the number of coverslips indicated in parentheses. The degrees of signi¢cance, deter-
mined using Student’s t-test for unpaired samples, for a comparison of values obtained in the presence of a given inhibitor with those
obtained in the absence of an inhibitor were: *P6 0.05; **P6 0.02; ***P6 0.01; and 3P6 0.001.
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The concentrations of verapamil, nifedipine, nicardi-
pine and AN1043 which gave half-maximal inhibi-
tion of thapsigargin-stimulated Ca2 in£ow were ap-
proximately 50, 100, 50 and 100 WM, respectively.
With the exception of verapamil and AN406, the
Ca2 antagonists had no substantial e¡ect on thap-
sigargin-induced release of Ca2 from the ER (Table
2).
It is possible that the inhibition of thapsigargin-
stimulated Ca2 in£ow by Ca2 antagonists is due
to the presence in H4-IIE cells of L-type VOCCs
or other types of VOCCs which are opened in re-
sponse to the action of thapsigargin (which may
lead to depolarisation of the plasma membrane)
and inhibited by VOCC Ca2 antagonists. This pos-
sibility was tested by determining whether depolar-
isation of the plasma membrane (induced by increas-
ing the extracellular K concentration) activates
Ca2 in£ow. In cells loaded with £uo-3 and incu-
bated in Krebs^Henseleit medium containing 1.3
mM Ca2o , an increase in the extracellular K
 con-
centration from 4.6 mM (116 mM extracellular Na)
to 100 mM (20.6 mM extracellular Na) (achieved
by replacing the normal Krebs^Henseleit medium
with the high K concentration medium either by
perfusing the cells or using a pipette) caused no in-
crease in intracellular £uorescence (data for 26 cells
in two separate experiments). This result suggests
that exposing the cells to high extracellular K con-
centration either does not induce Ca2 in£ow or does
induce Ca2 in£ow, but that Ca2 entering the cyto-
plasmic space through putative VOCCs is immedi-
ately taken up by the ER near the plasma membrane.
In order to test this last-mentioned possibility, the
experiment was repeated in the presence of 10 WM
thapsigargin. No increase in intracellular £uores-
cence was observed when the extracellular K con-
centration was increased from 4.6 to 100 mM in the
presence of thapsigargin (data for 16 cells). These
results con¢rm those reported previously by others
(reviewed in [14]) and indicate that it is unlikely that
H4-IIE cells possess a functional L-type VOCC
which is inhibited by VOCC antagonists.
Recently, Cao and Chatton [31] reported results
which suggest that calmodulin is involved in one of
the steps in the process by which RACCs in freshly
isolated rat hepatocytes are activated. Moreover,
other studies have shown that the HTC rat hepatoma
cell line expresses Ca2-activated plasma membrane
Ca2 channels [13]. Although the mechanism by
which Ca2 activates these channels in HTC cells
has not been elucidated, one possibility is that it in-
volves calmodulin. Moreover, it has been pointed out
by a number of authors that thapsigargin treatment
may initiate the activation not only of SOCs, but
also (via an increase in [Ca2]cyt) of Ca2-activated
Table 3
Inhibition of thapsigargin-induced release of Ca2 from intracellular stores and thapsigargin-stimulated Ca2 in£ow by calmodulin an-
tagonists
Calmodulin
antagonist
Calmodulin antagonist
concentration (WM)
Thapsigargin-induced
Ca2 release (nM)
Initial rate of thapsigargin-stimulated Ca2 in£ow (nM/s)
Antagonist added before
thapsigargin
Antagonist added after
thapsigargin
W7 0 197 þ 8 (13) 4.2 þ 0.1 (13) 4.2 þ 0.1 (13)
50 ^ ^ 1.9 þ 0.04 (5)*
100 0 (3) 0.4 þ 0.1 (3)* 1.6 þ 0.13 (5)*
150 ^ ^ 1.1 þ 0.11 (5)*
Calmidazolium 0 289 þ 17 (8) 5.9 þ 0.2 (8) 5.9 þ 0.2 (8)
3 ^ ^ 3.4 þ 0.07 (4)*
5 118 þ 8 (6)* 2.4 þ 0.1 (6)* ^
10 189 þ 14 (5)* 0.9 þ 0.04 (5)* 3.5 þ 0.4 (5)*
Measurement of the £uorescence of a ¢eld of H4-IIE cells loaded with £uo-3 and calculation of the amounts of Ca2 released from
intracellular stores and the initial rates of Ca2 in£ow were performed as described in Section 2. W7 or calmidazolium was added ei-
ther at the beginning of the period for the measurement of £uorescence (antagonist added before thapsigargin) or 5 min before the
addition of Ca2o (antagonist added after thapsigargin), as shown in Fig. 2. The degree of signi¢cance, determined using Student’s
t-test for unpaired samples, for a comparison of data obtained in the presence of a given inhibitor with that obtained in the absence
of the inhibitor was: *P6 0.001.
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RACCs (reviewed in [7]). In view of these observa-
tions, the role of calmodulin in thapsigargin-stimu-
lated Ca2 in£ow in H4-IIE cells was investigated
using four inhibitors of calmodulin action: W7
[32,33], W13 [32,34], calmidazolium [35,36] and
KN62 [37,38].
W13 caused a substantial inhibition of thapsigar-
gin-stimulated Ca2 in£ow when added either before
(Fig. 2A) or after (Fig. 2B) thapsigargin, and also
caused a substantial inhibition of thapsigargin-in-
duced Ca2 release (Fig. 2A). The concentrations
of W13 which gave half-maximal inhibition of thap-
sigargin-induced Ca2 release, thapsigargin-stimu-
lated Ca2 in£ow when W13 was added before thap-
sigargin, and thapsigargin-stimulated Ca2 in£ow
when W13 was added after thapsigargin, were ap-
proximately 40 WM (Fig. 3A), 20 WM (Fig. 3B) and
50 WM (Fig. 3C), respectively. W7 also inhibited
thapsigargin-stimulated Ca2 in£ow when the cal-
modulin antagonist was added either before or after
thapsigargin. When W7 was added before thapsigar-
gin, it also inhibited thapsigargin-induced Ca2 re-
Fig. 3. Dose^response curves for the inhibition by the calmodulin antagonist W13 of thapsigargin-induced release of Ca2 from intra-
cellular stores (A) and thapsigargin-stimulated Ca2 in£ow where W13 was added before (B) or after (C) thapsigargin. Measurement
of the £uorescence of a ¢eld of H4-IIE cells attached to collagen-coated coverslips and loaded with £uo-3, and calculation of the
amounts of Ca2 released and initial rates of Ca2 in£ow, were performed as described in Section 2. Each data point represents the
mean þ S.E.M. of the results obtained for three to seven separate experiments. The solid lines are a ¢t of the data points by eye.
Fig. 2. The inhibition of thapsigargin-stimulated Ca2 in£ow in H4-IIE cells by the calmodulin antagonist W13 added before (A) or
after (B) thapsigargin. H4-IIE cells attached to collagen-coated coverslips were loaded with £uo-3, and the £uorescence of a ¢eld of
cells measured as described in Section 2. The times of addition of W13 (60 WM) (the lower trace in each of A and B) are shown by
the horizontal open bar. The times of addition of thapsigargin (10 WM) and Ca2 (1.2 mM) are indicated by the arrows. (In the ex-
periment shown in B, Ca2 was added to control cells at 6 min and to cells treated with W13 at 13 min.) The traces shown are repre-
sentative of those obtained for one of four experiments which gave similar results.
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lease (Table 3). W7 was more e¡ective in inhibiting
thapsigargin-induced Ca2 in£ow when added before
rather than after thapsigargin (Table 3). Calmidazo-
lium caused some inhibition of thapsigargin-stimu-
lated Ca2 in£ow with a greater e¡ect when added
before thapsigargin (Table 3). Some inhibition by
calmidazolium of thapsigargin-induced Ca2 release
was also observed (Table 3). High concentrations of
calmidazolium (greater than 5 WM), W7 (100 WM)
and W13 (100 WM) caused changes in cell shape
and induced surface blebbing (results not shown).
These e¡ects are most likely due to inhibition of
the actions of calmodulin involved in other cellular
processes, such as regulation of the arrangement of
the cytoskeleton [39].
No inhibition of thapsigargin-induced Ca2 in£ow
was observed when 10 or 20 WM KN62 was added
after thapsigargin and 5 min before the addition of
Ca2 (10 WM KN62, 26 cells, two experiments; and
20 WM KN62, 14 cells, one experiment), and no in-
hibition of thapsigargin-induced Ca2 release or
Ca2 in£ow was observed when 20 WM KN62 was
added 5 min before thapsigargin addition (39 cells,
three experiments).
Taken together, the results described above indi-
cate that H4-IIE cells possess SOCs which are sensi-
tive to inhibition by Gd3, SKpF96365 and rela-
tively high concentrations of L-type VOCC
antagonists. Moreover, there is no evidence that the
activation of SOCs requires calmodulin.
3.3. Role of GTP-binding proteins in the activation of
Ca2+ in£ow
Previous studies [4,9,10] with freshly isolated rat
hepatocytes have shown that the activation of
Fig. 4. Comparison of the locations of the endoplasmic reticulum (A,B) and actin cytoskeleton (C,D) in freshly isolated rat hepato-
cytes (A,C) and H4-IIE cells (B,D). The isolation of rat hepatocytes, the attachment of freshly isolated rat hepatocytes to collagen-
coated coverslips for 2 h, the growth of H4-IIE cells, and detection of the ER using DiOC6(3) and the actin cytoskeleton using Texas
red-X phalloidin were performed as described in Section 2. Scale bar: 10 Wm. The images shown are representative of those obtained
for a single preparation.
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SOCs either by an agonist (such as vasopressin) or a
SERCA inhibitor is blocked by pretreatment with
pertussis toxin (which ADP-ribosylates the trimeric
proteins Gi1, Gi2 and Gi3 [40]) or brefeldin A (which
inhibits the actions of Arf monomeric G-proteins
[41]). These results indicated a requirement, in freshly
isolated rat hepatocytes, for a trimeric G-protein,
shown subsequently to be Gi2K [10], and a mono-
meric G-protein, possibly an Arf protein [4], in the
mechanism by which a decrease in the concentration
of Ca2 in the lumen of the ER activates SOCs. In
order to test whether Gi2K and a brefeldin-sensitive
protein are required in the process by which thapsi-
gargin stimulates Ca2 in£ow in H4-IIE cells, the
cells were pretreated with pertussis toxin (0.5 Wg/ml
for 20^24 h) or brefeldin A (20 WM). However, no
detectable inhibition of thapsigargin-stimulated Ca2
in£ow was observed. The rates of thapsigargin-
stimulated Ca2 in£ow in: (1) untreated H4-IIE cells
and H4-IIE cells treated with pertussis toxin were
9.3 þ 0.8 and 8.0 þ 0.8 nM/s, respectively (n = 6, two
cell preparations); and (2) untreated H4-IIE cells and
H4-IIE cells treated with brefeldin A were 9.3 þ 0.9
and 10.8 þ 1.1 nM/s, respectively (n = 6, two cell
preparations).
Since it has been proposed that the role of the G-
proteins in permitting the activation of SOCs in
freshly isolated rat hepatocytes is to maintain the
correct spatial locations of the actin cytoskeleton
and the ER, and/or intra-luminal communication
within the lumen of the ER [4], the arrangements
of the ER and actin cytoskeleton in H4-IIE cells
were determined in cells incubated under the condi-
tions employed for the measurement of Ca2 in£ow,
and compared with the organisation of the ER and
actin in freshly isolated rat hepatocytes. The distri-
bution of the ER, determined using DiOC6(3) [42], in
freshly isolated rat hepatocytes and in H4-IIE cells is
shown in Fig. 4A and B, respectively. Comparison of
the two sets of images indicates that a greater pro-
portion of the smaller H4-IIE cells is occupied by the
nucleus, and the distribution of the ER in H4-IIE
Fig. 5. The e¡ect of treatment with pertussis toxin on the location of the endoplasmic reticulum in H4-IIE cells (A,B) and freshly iso-
lated hepatocytes (C,D). Control cells, A and C and pertussis toxin-treated cells, B and D. The culture and treatment of H4-IIE cells
with pertussis toxin, the treatment of rats with pertussis toxin, the isolation of rat hepatocytes, the attachment of freshly isolated rat
hepatocytes to collagen-coated coverslips for 2 h and detection of the ER using DiOC6(3) were performed as described in Section 2.
Scale bar: 10 Wm. The images shown are representative of those obtained for a single preparation.
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cells is more punctate (Fig. 4B; cf. Fig. 4A). Com-
parison of the distribution of the F-actin cytoskele-
ton, determined using Texas red-X phalloidin [43],
indicates that most H4-IIE cells exhibit a di¡use ac-
tin cytoskeleton which extends into, or is chie£y
present in, most regions of the cytoplasmic space
(Fig. 4D). This contrasts with freshly isolated rat
hepatocytes which exhibit a clearly de¢ned cortical
actin skeleton and little detectable actin in other re-
gions of the cell (Fig. 4C) (cf. [44]).
The treatment of H4-IIE cells with pertussis toxin
caused no detectable change in the nature and distri-
bution of the ER, as observed using DiOC6(3) (Fig.
5B cf. Fig. 5A) although it was observed that pertus-
sis toxin treatment reduced the size (diameter) of the
cells. By contrast, the pretreatment of freshly isolated
rat hepatocytes with pertussis toxin caused a sub-
stantial change in the nature and distribution of the
ER, characterised principally by a more di¡use and
evenly distributed DiOC6(3) £uorescence signal (Fig.
5D cf. Fig. 5C).
In view of the di¡erent e¡ects of pertussis toxin
treatment on the activation of SOCs and on the na-
ture and distribution of the ER in H4-IIE cells com-
pared with freshly isolated rat hepatocytes, the na-
ture and amount of Gi2K in H4-IIE cells and freshly
isolated hepatocytes was determined using Western
blot analysis and an anti-Gi1=2 antibody. In whole
cell lysates of freshly isolated hepatocytes, two forms
of Gi2K , with apparent molecular weights of 41 and
43 kDa, were detected using Western blot analysis
(Fig. 6A) (cf. [45]). The 41-kDa form was shown to
have the same mobility as recombinant Gi2K (results
not shown), while the 43-kDa form is a phosphory-
lated form of Gi2K ([45] and results not shown). In
whole cell lysates of H4-IIE cells, only the 41-kDa
form of Gi2K was detected. Moreover, as judged from
the data shown in Fig. 6, in which the same amount
of lysate protein was applied to each gel, the total
amount of Gi2K protein (the sum of the 41 and 43
kDa forms) in H4-IIE cells is substantially less than
that in freshly isolated hepatocytes.
4. Discussion
4.1. The nature of plasma membrane Ca2+ channels
activated by thapsigargin treatment
The results show that H4-IIE cells possess RACCs
which admit Ca2, but not detectable amounts of
Mn2 ; are inhibited by Gd3 (an inhibitor of
VOCCs and SOCs [6,7,18]) at concentrations less
than 5 WM; are inhibited by SKpF 96365 (a non-
speci¢c inhibitor of RACCs [23]) at concentrations
less than 10^50 WM; are inhibited by L-type VOCC
antagonists [29] at concentrations in the range of 50^
100 WM; and are not inhibited by benzamil [25] at
concentrations shown by others to inhibit Na^Ca2
exchange [25]. The observation that pretreatment
with EGTA also activates SKpF 96365-sensitive
Ca2 in£ow, and the high sensitivity of thapsigar-
gin-stimulated Ca2 in£ow to inhibition by the lan-
thanide Gd3 (a characteristic of SOCs [6,7,18]) pro-
vide evidence that the observed thapsigargin-initiated
Ca2 in£ow is through SOCs (i.e. that activation of
the plasma membrane Ca2 channels is initiated by a
decrease in the concentration of Ca2 in the lumen of
the ER). The results obtained with EGTA and the
calmodulin antagonist KN62 indicate that the ob-
served thapsigargin-initiated plasma membrane
Ca2 in£ow is unlikely to be due to an increase in
[Ca2]cyt and the subsequent activation of Ca2-acti-
vated non-selective cation channels [6,7,13]). At-
tempts to ¢nd such a Ca2-activated channel in
H4-IIE cells using patch-clamp recording have not
been successful (G. Rychkov, L.M. Harland, H.
Brereton, and G.J. Barritt, unpublished results).
Since many other types of RACC, such as second
Fig. 6. Western blot analysis of Gi2 in H4-IIE cells and freshly
isolated rat hepatocytes. Freshly isolated hepatocytes (A) and
H4-IIE cells (B) were lysed and the whole lysates were quantita-
tively mixed with Laemmli sample bu¡er, subjected to SDS^
PAGE and Western blot analysis as described in Section 2. The
protein amount applied to the gel was 15 Wg for both samples.
The result shown is representative of two experiments con-
ducted each with a di¡erent cell preparation.
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messenger-activated non-selective cation channels,
admit Mn2 as well as Ca2 and have a relatively
low sensitivity to inhibition by lanthanides [5^7], the
observation that micromolar concentrations of Gd3
completely inhibit thapsigargin-stimulated Ca2 in-
£ow and the absence of detectable thapsigargin-ini-
tiated Mn2 in£ow indicate that only one type of
RACC, a SOC with a likely high selectivity for
Ca2, has been detected in the present study. The
results of experiments employing high extracellular
K to depolarise the plasma membrane provided
no evidence for the presence of functional VOCCs,
and are consistent with previous results in this and
other laboratories (reviewed in [14]). Thus H4-IIE
cells appear to di¡er from some apparently ‘non-ex-
citable’ cells, such as lymphocytes in which VOCCs
play a role in agonist-induced Ca2 in£ow [28].
The observation that SOCs in H4-IIE cells are in-
hibited by L-type VOCC antagonists, although at
concentrations substantially higher than those which
inhibit L-type VOCCs, suggests that SOCs in H4-IIE
cells exhibit some features of the recently de¢ned
dihydropyridine Ca2 antagonist multisubsite bind-
ing domain [46]. The pattern of inhibition of H4-
IIE cell SOCs by VOCC antagonists resembles that
for the inhibition of T-type VOCCs, namely inhibi-
tion by high concentrations of L-type Ca2 antago-
nists and resistance to inhibition by calciseptine [47].
Moreover, the results of a previous study with rat
hepatocytes, which employed a variety of di¡erent
lanthanides, led to the conclusion that the pore of
the vasopressin-stimulated Ca2 channel exhibits
characteristics of the pore of T-type VOCCs [18].
Furthermore, mRNA encoding potentially interest-
ing unusual isoforms of L-type VOCCs has been
detected in H4-IIE cells [14]. These several observa-
tions, together with other similarities between SOCs
and VOCCs such as a high selectivity for Ca2 (re-
viewed in [6]) suggest that SOCs in H4-IIE cells and
in some other cell types such as lymphocytes and
mast cells, exhibit some VOCC characteristics (cf.
[14]).
The properties of the SOCs in H4-IIE cells de-
scribed here are similar to those previously described
for SOCs in rat hepatocytes. The latter are inhibited
by low concentrations of Gd3 [18], by SKpF 96365
[48], and by relatively high concentrations of L-type
VOCC antagonists [26,27]. In the present study with
H4-IIE cells, no Mn2 in£ow through SOCs was
detected. While this observation di¡ers from the re-
sults obtained with rat hepatocytes by some workers
who observed agonist- or thapsigargin-stimulated
Mn2 in£ow [18,49^51], the observed rate of agonist-
or thapsigargin-stimulated Mn2 in£ow was often
very low, and the nature of the channel involved (a
SOC or another type of RACC) was not always well
de¢ned (cf. [50,52]). Moreover, other groups have
reported that, although Mn2 in£ow through SOCs
could not be detected in rat hepatocytes, there is
evidence for another type of RACC (not a SOC)
which does admit Mn2 [50,52]. Thus it is likely
that freshly isolated rat hepatocytes do, indeed, ad-
mit Mn2 through an RACC sub-type which is not
an SOC, and that this type of Mn2-permeable
RACC sub-type was not detected in the present
study with H4-IIE cells. This may be because an
appropriate agonist was not employed to initiate
the activation of this (and possibly other) RACC
sub-type which may be present in H4-IIE cells.
The properties exhibited by SOCs in H4-IIE cells
(sensitivity to inhibition by micromolar concentra-
tions of Gd3, inhibition by SKpF 96365 and no
detectable Mn2 in£ow) are consistent with those
described for the Ca2 release-activated Ca2 cur-
rents (ICRAC) in some other cell types (reviewed in
[6]). However, they are generally not consistent with
the properties of most of the TRP homologues which
have a relatively low selectivity for Ca2 compared
with Na, are only inhibited by higher concentra-
tions of lanthanides, admit Mn2 and often do not
appear to be activated by a decrease in the concen-
tration of Ca2 in the ER [5^8]. While there are few
reports of SOCs which are inhibited by VOCC Ca2
antagonists, VOCC-like characteristics (inhibition by
g-conotoxins and other inhibitors of non-L-type
VOCCs) have been reported for SOCs in Xenopus
laevis oocytes [53] and in skeletal muscle cells where
it was shown that the novel dihydropyridines,
AN406 and AN1043, inhibit Ca2 in£ow through a
Ca2-speci¢c leak channel which is activated by a
decrease in Ca2 in the sarcoplasmic reticulum [30].
4.2. Evaluation of the role of calmodulin in the
activation of SOCs
While three of the four calmodulin inhibitors
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tested inhibited thapsigargin-stimulated plasma
membrane Ca2 in£ow, KN62, a reasonably speci¢c
calmodulin inhibitor [37,38], did not inhibit this pro-
cess. Moreover, W7, W13 and calmidazolium, inhib-
ited thapsigargin-induced release of Ca2 from intra-
cellular stores as well as Ca2 in£ow and, at higher
concentrations, a¡ected cell shape. It is concluded
from all these results that calmodulin is not required
for either the activation of plasma membrane Ca2
in£ow or the release of Ca2 from the ER, initiated
by the action of thapsigargin on H4-IIE cells. The
observed inhibition of Ca2 release from the ER by
W7, W13 and calmidazolium may re£ect the interac-
tion of these compounds with one or more calmod-
ulin-independent protein kinases or other proteins
which are also a¡ected by W7, W13 and calmidazo-
lium [34,36^38,54], and which may be involved, di-
rectly or indirectly, in regulating the release of Ca2
from the ER. The inhibition of Ca2 in£ow may be a
consequence of inhibition of the release of Ca2 from
intracellular stores, or may be due to a direct inter-
action between the calmodulin antagonist and the
SOC protein [39,54]. The conclusion that calmodulin
is not required for the activation of SOCs in H4-IIE
cells di¡ers from that reached by Cao and Chatton
[31] for rat hepatocytes. This may re£ect a role for
calmodulin in the activation of an RACC sub-type
which is not an SOC, but is present in rat hepato-
cytes and was activated under the conditions em-
ployed.
4.3. The role of G-proteins in the activation of SOCs
No evidence was obtained to indicate that Gi2K- or
a brefeldin A-sensitive protein (possibly the Arf
monomeric G-protein) are involved in the activation
of SOCs in H4-IIE cells. This contrasts with results
obtained previously with freshly isolated rat hepato-
cytes [4,9,10]. It has been proposed that the require-
ment for these G-proteins in the activation of SOCs
in rat hepatocytes re£ects their role in regulation of
the actin cytoskeleton which, in turn, is responsible
for maintenance of the correct spatial location of the
ER and maintenance of communication within the
lumen of the ER [4]. Most other cell types do not
appear to require Gi2K for the activation of SOCs [7].
However, there is evidence that a monomeric G-pro-
tein is required for the activation of SOCs in several
cell types, although the function of such a protein
has not been de¢ned [7].
Di¡erences were observed between H4-IIE cells
and freshly isolated hepatocytes in the arrangement
of F-actin and the ER, in the e¡ect of pertussis toxin
treatment on the distribution of the ER, in the
amount of total Gi2K protein (expressed as a fraction
of total cell protein) and in the ratio of the 41 and 43
kDa forms of Gi2K (only the 41-kDa form was de-
tected in H4-IIE cells). The last-mentioned observa-
tion may re£ect di¡erences in the activity and/or lo-
cation of protein kinases and phosphoprotein
phosphatases for which Gi2K is a substrate. The ab-
sence of the requirement for Gi2 and a brefeldin A-
sensitive protein in the activation of SOCs in H4-IIE
cells compared with freshly isolated rat hepatocytes
may re£ect di¡erences in the arrangement of the cy-
toskeleton and ER in relation to the location of
SOCs, and/or in the function and distribution of
Gi2K . The present conclusion that H4-IIE cells con-
tain less total Gi2K than freshly isolated hepatocytes
di¡ers from that of McKillop et al. [55] who con-
cluded that cells in hepatocellular carcinomas derived
from H4-IIE cells express higher amounts of Gi pro-
teins. These di¡erent conclusions may be due to the
fact that the present study measured Gi2K in whole
cell lysates, whereas McKillop et al. measured Gi2K in
plasma membrane fractions.
The identi¢cation of SOCs in H4-IIE cells with
properties similar to SOCs in rat hepatocytes indi-
cates that H4-IIE cells can be used in future studies
of the properties and structure of liver cell SOCs.
Moreover, the absence of a requirement for Gi2 in
SOC activation in H4-IIE cells may assist in elucidat-
ing the role played by this G-protein in freshly iso-
lated rat hepatocytes. The availability of an immor-
talised cell line for these studies will be particularly
useful in experiments which employ antisense DNA,
or DNA encoding dominant negative mutant forms
of G-proteins, since it has been shown that H4-IIE
cells can be readily transfected with exogenous DNA
[56].
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